跳到正文
原文
Endpoints News 生物医药· Lei Lei Wu·· 3 天前AI 评分35

Lilly 与 Stipple Bio 签订 59 亿美元癌症治疗合作协议

Lilly strikes up to $5.9B cancer deal with Stipple Bio

AI 导读

李利公司继续其在制药领域的并购活动,与位于马萨诸塞州剑桥的 Stipple Bio 公司签订了一项价值 59 亿美元的合作协议,旨在开发新的癌症治疗方法。

正文

Eli Lil­ly con­tin­ues to be phar­ma’s biggest shopa­holic.

Lil­ly has en­list­ed Cam­bridge, MA-based start­up Stip­ple Bio for a multi­bil­lion-dol­lar deal to de­vel­op new can­cer treat­ments …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news